Genmab A/S (GNMSF) Gross Profit (2024 - 2026)
Genmab A's (GNMSF) quarterly Gross Profit came in at $831.0 million in Q1 2026, up 23.48% YoY from $673.0 million in Q1 2025, and down 66.83% on a QoQ basis from $2.5 billion in Q3 2025.
Genmab A/S (GNMSF) Gross Profit (2024 - 2026) Analysis & Trends
Genmab A (GNMSF) has 3 years of Gross Profit data on file, last reported at $831.0 million in Q1 2026.
- Quarterly Gross Profit rose 23.48% year-over-year to $831.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.6 billion (up 18.62% YoY) and the FY2025 annual result came in at $3.5 billion, up 16.92% from the prior year.
- Gross Profit eased to $831.0 million in Q1 2026, from $2.5 billion in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $2.5 billion in Q3 2025 to a low of $576.0 million in Q1 2024.
- A 3-year average of $1.4 billion and a median of $1.3 billion in 2024 frame the typical range for Gross Profit.
- Annual changes were most pronounced in 2025 — Gross Profit rose 16.13% — and 2026, when it increased 23.48%.
- Tracing GNMSF's Gross Profit over 3 years: stood at $2.1 billion in 2024, then rose by 19.12% to $2.5 billion in 2025, then plunged by 66.83% to $831.0 million in 2026.
- The last three Gross Profit figures came in at $831.0 million (Q1 2026), $2.5 billion (Q3 2025), and $1.5 billion (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.07 Bn |
| Jun 30, 2026 | 1.07 Bn |
| Mar 31, 2026 | 831.00 Mn |
| Mar 31, 2026 | 831.00 Mn |
| Sep 30, 2025 | 2.51 Bn |
| Sep 30, 2025 | 2.51 Bn |
| Jun 30, 2025 | 1.54 Bn |
| Jun 30, 2025 | 1.54 Bn |
| Mar 31, 2025 | 673.00 Mn |
| Mar 31, 2025 | 673.00 Mn |
| Sep 30, 2024 | 2.10 Bn |
| Sep 30, 2024 | 2.10 Bn |
| Jun 30, 2024 | 1.33 Bn |
| Jun 30, 2024 | 1.33 Bn |
| Mar 31, 2024 | 576.00 Mn |
| Mar 31, 2024 | 576.00 Mn |